title: Quantitative characterization of eye tracking dysfunction in schizophrenia.
abstract: The purpose of this study was to characterize the nature of the processes that are involved in eye tracking dysfunction (ETD). We identified a combination of quantitative measures that best distinguished qualitatively normal eye tracking from qualitatively abnormal eye tracking, using discriminant analysis. Discriminant scores distinguished schizophrenics with ETD from both schizophrenics with normal eye tracking and normal controls, but did not distinguish schizophrenics with normal eye tracking from normal controls, underscoring the heterogeneity of schizophrenic patients with respect to eye tracking. The results of the discriminant analysis indicated that ETD is a multivariate process involving a primary impairment in the smooth pursuit system characterized by increased catch-up saccades and reduced gain, and, secondarily, disinhibition of intrusive saccades, especially square-wave jerks. Quantitative characterization of ETD makes it possible to consider eye tracking as a quantitative trait in genetic investigations of a multidimensional phenotype.
authors.affiliation: Department of Psychology, Washington University, St. Louis, MO, USA. levy@wjh.harvard.edu
authors.forename: D L
authors.initials: DL
authors.lastname: Levy
authors.forename: C M
authors.initials: CM
authors.lastname: Lajonchere
authors.forename: B
authors.initials: B
authors.lastname: Dorogusker
authors.forename: D
authors.initials: D
authors.lastname: Min
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: A
authors.initials: A
authors.lastname: Tartaglini
authors.forename: J A
authors.initials: JA
authors.lastname: Lieberman
authors.forename: N R
authors.initials: NR
authors.lastname: Mendell
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D015835:Ocular Motility Disorders / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology*; D011930:Reaction Time; D012438:Saccades; D012559:Schizophrenia / Q000150:complications*